Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 445

    1.

    Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes.

    Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K.

    Diabetes Care. 2004 Apr;27(4):963-6.PMID: 15047656 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children.

    Chessa M, Butera G, Lanza GA, Bossone E, Delogu A, De Rosa G, Marietti G, Rosti L, Carminati M.

    Herz. 2002 Dec;27(8):785-90.PMID: 12574897 [PubMed - indexed for MEDLINE]Related articles

    3.

    Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes.

    Larsen JR, Sjoholm H, Hanssen KF, Sandvik L, Berg TJ, Dahl-Jorgensen K.

    Diabetes Care. 2003 Aug;26(8):2400-4.PMID: 12882869 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    [Insulin therapy improves cardiac autonomic function in type 2 diabetic patients]

    Schnell O, Kilinc S, Rambeck A, Standl E.

    Herz. 2004 Aug;29(5):519-23. German. PMID: 15340738 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    6.

    Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy.

    Pagkalos M, Koutlianos N, Kouidi E, Pagkalos E, Mandroukas K, Deligiannis A.

    Br J Sports Med. 2008 Jan;42(1):47-54. Epub 2007 May 25.PMID: 17526623 [PubMed - indexed for MEDLINE]Related articles

    9.

    Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.

    Mäkimattila S, Schlenzka A, Mäntysaari M, Bergholm R, Summanen P, Saar P, Erkkilä H, Yki-Järvinen H.

    Diabetes Care. 2000 Nov;23(11):1686-93.PMID: 11092293 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy.

    Burger AJ, Weinrauch LA, D'Elia JA, Aronson D.

    Am J Cardiol. 1999 Sep 15;84(6):687-91.PMID: 10498140 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients.

    Ziegler D, Dannehl K, Volksw D, Mühlen H, Spüler M, Gries FA.

    Diabetes Care. 1992 Jul;15(7):908-11.PMID: 1516513 [PubMed - indexed for MEDLINE]Related articles

    16.

    Autonomic neuropathy--a complication less pronounced in patients with Type 1 diabetes mellitus who have lower blood glucose levels.

    Reichard P, Jensen-Urstad K, Ericsson M, Jensen-Urstad M, Lindblad LE.

    Diabet Med. 2000 Dec;17(12):860-6.PMID: 11168329 [PubMed - indexed for MEDLINE]Related articles

    17.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impact of glycemic control, disease duration, and exercise on heart rate variability in children with type 1 diabetes mellitus.

    Chen SR, Lee YJ, Chiu HW, Jeng C.

    J Formos Med Assoc. 2007 Nov;106(11):935-42.PMID: 18063515 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).

    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.

    Endocr J. 2007;54(6):975-83. Epub 2007 Nov 14.PMID: 18000343 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data